Toronto - Delayed Quote CAD
Cipher Pharmaceuticals Inc. (CPH.TO)
12.78
-0.42
(-3.18%)
At close: May 13 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 10.74M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Wolkin (Harold Morton) Director of Issuer | Acquisition or disposition under a purchase/ownership plan at price 8.14 per share. | Direct | 3,346 | Apr 15, 2025 |
| Wolkin (Harold Morton) Director of Issuer | Exercise of options at price 3.53 per share. | Direct | 12,369 | Mar 24, 2025 |
| Wolkin (Harold Morton) Director of Issuer | Acquisition or disposition in the public market at price 9.42 per share. | Direct | 32,977 | Mar 24, 2025 |
| Wolkin (Harold Morton) Director of Issuer | Exercise of options at price 2.46 per share. | Direct | 8,627 | Mar 24, 2025 |
| Wolkin (Harold Morton) Director of Issuer | Acquisition or disposition in the public market at price 9.42 per share. | Direct | 32,977 | Mar 24, 2025 |
| Wolkin (Harold Morton) Director of Issuer | Acquisition or disposition under a purchase/ownership plan at price 8.34 per share. | Direct | 3,259 | Mar 19, 2025 |
| Wolkin (Harold Morton) Director of Issuer | Acquisition or disposition under a purchase/ownership plan at price 9.17 per share. | Direct | 3,300 | Feb 14, 2025 |
| Wolkin (Harold Morton) Director of Issuer | Acquisition or disposition under a purchase/ownership plan at price 9.64 per share. | Direct | 3,259 | Jan 15, 2025 |
| Wolkin (Harold Morton) Director of Issuer | Acquisition or disposition under a purchase/ownership plan at price 10.38 per share. | Direct | 3,260 | Dec 16, 2024 |
| Wolkin (Harold Morton) Director of Issuer | Acquisition or disposition under a purchase/ownership plan at price 9.31 per share. | Direct | 3,303 | Nov 15, 2024 |
| Wolkin (Harold Morton) Director of Issuer | Acquisition or disposition under a purchase/ownership plan at price 12.49 per share. | Direct | 3,383 | Oct 16, 2024 |
| Wolkin (Harold Morton) Director of Issuer | Acquisition or disposition under a purchase/ownership plan at price 10.24 per share. | Direct | 3,398 | Aug 16, 2024 |
| Wolkin (Harold Morton) Director of Issuer | Acquisition or disposition under a purchase/ownership plan at price 6.11 per share. | Direct | 3,402 | Jul 16, 2024 |
| Wolkin (Harold Morton) Director of Issuer | Acquisition or disposition under a purchase/ownership plan at price 6.32 per share. | Direct | 3,392 | Jun 17, 2024 |
| Wolkin (Harold Morton) Director of Issuer | Acquisition or disposition under a purchase/ownership plan at price 6.60 per share. | Direct | 3,419 | May 16, 2024 |
Related Tickers
RX.V BioSyent Inc.
10.80
-0.74%
HASH.V SIMPLY SOLVENTLESS CONCENTRATES
0.4400
0.00%
MOB.ST Moberg Pharma AB (publ)
7.55
+2.72%
SBBC.V Simply Better Brands Corp.
1.0100
+4.12%
MDP.TO Medexus Pharmaceuticals Inc.
2.5900
-5.13%
GUD.TO Knight Therapeutics Inc.
5.81
-0.85%
CRON.TO Cronos Group Inc.
2.8300
-1.05%
HLS.TO HLS Therapeutics Inc.
4.6800
+4.00%
BHC.TO Bausch Health Companies Inc.
6.51
-2.69%
OGI.TO Organigram Global Inc.
1.7200
-4.44%